Functionalized glycomers as growth inhibitors and inducers of apoptosis in human glioblastoma cells

Journal of Medicinal Chemistry

Volumn 46, Issue 17, 2003, Pages 3600-3611

  Hanessian, Stephen ^a   Zhan, Lijie ^a   Bovey, Raymonde ^b   Saavedra, Oscar M ^a   Juillerat Jeanneret, Lucienne ^b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEXTRO GLYCOPYRANOSIDE DERIVATIVE; GLYCOPYRANOSIDE; GROWTH INHIBITOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; GLIOBLASTOMA; HUMAN; HUMAN CELL; TUMOR GROWTH;

APOPTOSIS; BRAIN NEOPLASMS; CELL DIVISION; CELL LINE; CEREBRAL CORTEX; ENDOTHELIUM; FIBROBLASTS; GLIOBLASTOMA; GLUCOSIDES; HUMANS; TUMOR CELLS, CULTURED;

EID: 0042066522     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0205853     Document Type: Article

References (20)

1. Bredel, M. Anticancer drug resistance in primary human brain tumors. Brain Res. Rev. 2001, 35, 161-204.
2. Brandes, A. A.; Basso, U.; Pasetto, L. M.; Ermani, M. New strategy development in brain tumor therapy. Curr. Pharm. Des. 2001, 7, 1553-1580.
3. Berens, M. E.; Giese, A. Biology and oncology ofinvasive glioma cells. Neoplasia 1999, 1, 208-219.
4. Prados, M. D.; Levin, V. Biology and treatment of malignant glioma. Sem. Oncol. 2000, 27, 1-10.
5. Hofer, S.; Herrmann, R. Chemotherapy for malignant brain tumors of astrocytic and oligodendroglial lineage. J. Cancer Res. Clin. Oncol. 2001, 127, 91-95.
6. Newton, H. B. Novel chemotherapeutic agents for the treatment of brain cancer. Exp. Opinion Invest. Drugs 2000, 9, 2815-2829.
7. Nieto-Sampedro, M.; Bailon, C.; Fernandez-Mayoralas, A.; Martin-Lomas, M.; Mellström, B.; Naranjo, J. R. Experimental brain glioma: growth arrest and destruction by a blood-group-related tetrasaccharide. J. Neuropath. Exp. Neurol. 1996, 55, 169-177.
8. Aguilera, B.; Romera-Ramirez, L.; Abad-Rodriguez, J.; Corrales, G.; Nieto-Sampiedro, M. Novel disaccharide inhibitors of human glioblastoma cell division. J. Med. Chem. 1998, 41, 4599-4606.
9. Camby, I.; Decaestecker, C.; Gordower, L.; DeDecker, R.; Kacem, Y.; Lemmers, A.; Siebert, H. C.; Bovin, N. V.; Wesseling, P.; Danguy, A.; Salmon, I.; Gabius, H. J.; Kiss, R. Distinct differences in binding capacity to saccharide epitopes in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas. J. Neuropath. Exp. Neurol. 2001, 60, 75-84.
10. Hanessian, S.; Saavedra, O. M.; Xie, F.; Amboldi, N.; Battistini, C. Design and synthesis of functionalized glycomers as nonpeptidic ligands for SH2 binding and as inhibitors of A-431 human epidermoid and HT-29 colon carcinoma cell lines. Bioorg. Med. Chem. Lett. 2000, 10, 439-442.
11. Bessel, E. M.; Westwood, J. M. (R,S)-2,3-Ethoxypropyl ethers and glycosides of D-glucopyranose. Carbohydr. Res. 1992, 25, 11-21.
12. Ogawa, T.; Matsui, M. An approach to the synthesis of glycosides: enhancement of nucleophilicity of hydroxyl gorups by trialkylstannylation. Carbohydr. Res. 1976, 51, C13-C18.
13. Garegg, P.; Hultberg, H.; Wallin, S. A novel reductive ring opening of carbohydrate benzylidene acetals. Carbohdr. Res. 1982, 108, 97-101.
14. Diserens, A. C.; de Tribolet, N.; Martin-Achard, G.; Gaide, A. C.; Schnegg J. F.; Carrel, S. Characterization of an established human malignant glioma cell line: LN18. Acta Neuropathol. 1981, 53, 21-28.
15. Muruganandan A.; Herz, L. M.; Monette, R.; Durkin, J. P.; Stanimirovic, D. Development of immortalized human cerebrovascular endothelial cell line as an in vitro model of the human blood-brain barrier. FASEB J. 1997, 11, 1187-1197.
16. Uehlinger, P.; Zellweger, M.; Wagnières, G.; Juillerat-Jeanneret, L.; van den Bergh, H.; Lange, N. 5-aminolevulinic acid and its derivatives: physical chemical properties and protoporphyrin IX formation in cultured cells. J. Photochem. Photobiol. B: Biol. 2000, 54, 72-80.
17. Agbaria, R.; Kelley, J. A.; Jackman, J.; Viola, J. J.; Ram, Z.; Oldfield, E.; Johns, D. G. Antiproliferative effects of cyclopentenyl cytosine (NSC 375575) in human glioblastoma cells. Oncol. Res. 1997, 11-118, 1997.
18. Egidy, G.; Peduto Eberl, L.; Valdenaire, O.; Irmler, M.; Majdi, R.; Diserens, A. C.; Fontana, A.; Janzer, R. C.; Pinet, F.; Juillerat-Jeanneret, L. The endothelin system in human glioblastoma. Lab. Invest. 2000, 80, 1681-1689.
19. Uckun, F. M. Rationally designed anti-mitotic agents with promitotic activity. Curr. Pharm. Des. 2001, 7, 1627-1639.
20. Peduto Eberl, L.; Valdenaire, O.; Saintgiorgio, V.; Jeannin, J. F.; Juillerat-Jeanneret, L. Endothelin receptor blockade potentiates FasL-induced apoptosis in rat colon carcinoma cells. Int. J. Cancer 2000, 86, 182-187.